S&P 500   3,902.77 (-0.53%)
DOW   31,243.05 (-0.78%)
QQQ   289.06 (-0.71%)
AAPL   137.39 (-2.44%)
MSFT   253.27 (-0.32%)
FB   191.92 (-0.17%)
GOOGL   2,211.56 (-1.18%)
AMZN   2,157.13 (+0.69%)
TSLA   711.53 (+0.24%)
NVDA   172.47 (+1.82%)
BABA   88.18 (+1.00%)
NIO   16.68 (+5.37%)
AMD   97.82 (+1.60%)
CGC   5.87 (+5.01%)
MU   69.50 (-2.18%)
T   20.12 (-0.54%)
GE   75.52 (+0.43%)
F   12.90 (+0.94%)
DIS   103.29 (-0.97%)
AMC   12.77 (+0.08%)
PFE   50.27 (-0.26%)
PYPL   81.28 (+5.31%)
NFLX   184.51 (+4.13%)
S&P 500   3,902.77 (-0.53%)
DOW   31,243.05 (-0.78%)
QQQ   289.06 (-0.71%)
AAPL   137.39 (-2.44%)
MSFT   253.27 (-0.32%)
FB   191.92 (-0.17%)
GOOGL   2,211.56 (-1.18%)
AMZN   2,157.13 (+0.69%)
TSLA   711.53 (+0.24%)
NVDA   172.47 (+1.82%)
BABA   88.18 (+1.00%)
NIO   16.68 (+5.37%)
AMD   97.82 (+1.60%)
CGC   5.87 (+5.01%)
MU   69.50 (-2.18%)
T   20.12 (-0.54%)
GE   75.52 (+0.43%)
F   12.90 (+0.94%)
DIS   103.29 (-0.97%)
AMC   12.77 (+0.08%)
PFE   50.27 (-0.26%)
PYPL   81.28 (+5.31%)
NFLX   184.51 (+4.13%)
S&P 500   3,902.77 (-0.53%)
DOW   31,243.05 (-0.78%)
QQQ   289.06 (-0.71%)
AAPL   137.39 (-2.44%)
MSFT   253.27 (-0.32%)
FB   191.92 (-0.17%)
GOOGL   2,211.56 (-1.18%)
AMZN   2,157.13 (+0.69%)
TSLA   711.53 (+0.24%)
NVDA   172.47 (+1.82%)
BABA   88.18 (+1.00%)
NIO   16.68 (+5.37%)
AMD   97.82 (+1.60%)
CGC   5.87 (+5.01%)
MU   69.50 (-2.18%)
T   20.12 (-0.54%)
GE   75.52 (+0.43%)
F   12.90 (+0.94%)
DIS   103.29 (-0.97%)
AMC   12.77 (+0.08%)
PFE   50.27 (-0.26%)
PYPL   81.28 (+5.31%)
NFLX   184.51 (+4.13%)
S&P 500   3,902.77 (-0.53%)
DOW   31,243.05 (-0.78%)
QQQ   289.06 (-0.71%)
AAPL   137.39 (-2.44%)
MSFT   253.27 (-0.32%)
FB   191.92 (-0.17%)
GOOGL   2,211.56 (-1.18%)
AMZN   2,157.13 (+0.69%)
TSLA   711.53 (+0.24%)
NVDA   172.47 (+1.82%)
BABA   88.18 (+1.00%)
NIO   16.68 (+5.37%)
AMD   97.82 (+1.60%)
CGC   5.87 (+5.01%)
MU   69.50 (-2.18%)
T   20.12 (-0.54%)
GE   75.52 (+0.43%)
F   12.90 (+0.94%)
DIS   103.29 (-0.97%)
AMC   12.77 (+0.08%)
PFE   50.27 (-0.26%)
PYPL   81.28 (+5.31%)
NFLX   184.51 (+4.13%)
ETR:COP

CompuGroup Medical SE & Co. KGaA (COP) Stock Forecast, Price & News

€50.05
-0.80 (-1.57%)
(As of 05/18/2022 12:00 AM ET)
Add
Compare
Today's Range
€49.84
€50.85
50-Day Range
€45.38
€58.15
52-Week Range
€44.40
€82.80
Volume
38,050 shs
Average Volume
68,245 shs
Market Capitalization
$2.62 billion
P/E Ratio
38.50
Dividend Yield
1.01%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive COP News and Ratings via Email

Sign-up to receive the latest news and ratings for CompuGroup Medical SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

CompuGroup Medical SE & Co. KGaA logo

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.

Headlines

CompuGroup Medical SE & Co KgaA
CompuGroup Medical agrees to acquire INSIGHT Health
CGM lab software modernizes healthcare in Timor-Leste
See More Headlines

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
8,598
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.06 billion
Cash Flow
€2.14 per share
Book Value
€11.70 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$2.62 billion
Optionable
Optionable

Company Calendar

Today
5/19/2022
Next Earnings (Estimated)
8/04/2022

MarketRank

Overall MarketRank

1.73 out of 5 stars

Analyst Opinion: 3.0Community Rank: 4.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













CompuGroup Medical SE & Co. KGaA (ETR:COP) Frequently Asked Questions

Is CompuGroup Medical SE & Co. KGaA a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CompuGroup Medical SE & Co. KGaA in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CompuGroup Medical SE & Co. KGaA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in COP, but not buy additional shares or sell existing shares.
View analyst ratings for CompuGroup Medical SE & Co. KGaA
or view top-rated stocks.

When is CompuGroup Medical SE & Co. KGaA's next earnings date?

CompuGroup Medical SE & Co. KGaA is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for CompuGroup Medical SE & Co. KGaA
.

Is CompuGroup Medical SE & Co. KGaA a good dividend stock?

CompuGroup Medical SE & Co. KGaA pays an annual dividend of €0.50 per share and currently has a dividend yield of 1.01%. The dividend payout ratio of CompuGroup Medical SE & Co. KGaA is 38.46%. This payout ratio is at a healthy, sustainable level, below 75%.

What price target have analysts set for COP?

2 brokers have issued 12-month target prices for CompuGroup Medical SE & Co. KGaA's stock. Their forecasts range from €59.00 to €88.00. On average, they expect CompuGroup Medical SE & Co. KGaA's share price to reach €74.86 in the next twelve months. This suggests a possible upside of 49.6% from the stock's current price.
View analysts' price targets for CompuGroup Medical SE & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are CompuGroup Medical SE & Co. KGaA's key executives?
CompuGroup Medical SE & Co. KGaA's management team includes the following people:
  • Mr. Frank Gotthardt, Chairman of Management Board (Age 72, Pay $800k)
  • Mr. Michael Rauch L.L.M., M.B.A., CFO & Member of Management Board (Age 50, Pay $1.24M)
  • Mr. Hannes Reichl, MD of Impatient & Social Care and Member of the Management Board (Age 46, Pay $766.28k)
  • Mr. Frank Brecher, CTO, MD & Member of Management Board (Age 53, Pay $608.62k)
  • Dr. Eckart Pech, MD of Consumer & Health Management Information Systems and Member of the Management Board (Age 53, Pay $772.5k)
  • Mr. Sven Thomas Muller, Chief Information Officer (Age 43)
  • Dr. Dirk Wossner, MD, CEO & Member of Management Board (Age 53)
  • Ms. Claudia Thomé, Corp. VP of Investor Relations (Age 51)
  • Ms. Agnieszka Mogelin-Zinger, Global Gen. Counsel
  • Alexander Weimer, Head of Corp. & Co-Head of Brand Communications
What other stocks do shareholders of CompuGroup Medical SE & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CompuGroup Medical SE & Co. KGaA investors own include Netflix (NFLX), Whiting Petroleum (WLL), NovelStem International (HOLL), (KOG) (KOG), Vaccinex (VCNX), Whiting USA Trust II (WHZT), Microchip Technology (MCHP), NVIDIA (NVDA), (AAXN) and Applegreen (APGN).

What is CompuGroup Medical SE & Co. KGaA's stock symbol?

CompuGroup Medical SE & Co. KGaA trades on the ETR under the ticker symbol "COP."

What is CompuGroup Medical SE & Co. KGaA's stock price today?

One share of COP stock can currently be purchased for approximately €50.05.

How much money does CompuGroup Medical SE & Co. KGaA make?

CompuGroup Medical SE & Co. KGaA has a market capitalization of $2.62 billion and generates $1.06 billion in revenue each year.

How many employees does CompuGroup Medical SE & Co. KGaA have?

CompuGroup Medical SE & Co. KGaA employs 8,598 workers across the globe.

What is CompuGroup Medical SE & Co. KGaA's official website?

The official website for CompuGroup Medical SE & Co. KGaA is www.cgm.com.

How can I contact CompuGroup Medical SE & Co. KGaA?

CompuGroup Medical SE & Co. KGaA's mailing address is Maria Trost 21, KOBLENZ, 56070, Germany. The company can be reached via phone at +49-261-80000.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.